NCT05334017View on ClinicalTrials.gov

Xylometazoline and Cocaine for Nasal Vasoconstriction

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

March 21, 2023

Study Completion Date

March 22, 2023

Conditions
Epistaxis
Interventions
DRUG

Xylometazoline 0,1%

1 ml of 0,1% xylometazoline diluted with 1 ml of 0,9% isotonic saline solution given as a nasal spray

DRUG

Cocaine 4%

2 ml of 4% cocaine given as a nasal spray

Trial Locations (1)

2100

Rigshospitalet, Copenhagen University Hospital, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER